In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New measures to limit the unavailability of medicines – Impact on professional stakeholders

New measures to limit the unavailability of medicines – Impact on professional stakeholders

by In2Pharma | Jun 7, 2019 | News

Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...

Recent Posts

  • Updates to the Dutch Medicines Act
  • Update LCPV notification form
  • EC Regulation impacting pharmacovigilance
  • Recent Updates to GVP Guidance Documents
  • New hourly fees for the Netherlands for 2026

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België